Compile Data Set for Download or QSAR
maximum 50k data
Found 90 of ec50 data for polymerid = 7498
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207889(US9266832, Cpd046)
Affinity DataEC50:  7nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207891(US9266832, Cpd048 | US9266832, Cpd084)
Affinity DataEC50:  13nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207875(US9266832, Cpd032)
Affinity DataEC50:  14nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207874(US9266832, Cpd031)
Affinity DataEC50:  16nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207920(US9266832, Cpd077)
Affinity DataEC50:  17nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207896(US9266832, Cpd053)
Affinity DataEC50:  17nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207923(US9266832, Cpd080)
Affinity DataEC50:  18nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207895(US9266832, Cpd052)
Affinity DataEC50:  20nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207882(US9266832, Cpd039)
Affinity DataEC50:  22nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207888(US9266832, Cpd045)
Affinity DataEC50:  22nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207924(US9266832, Cpd081)
Affinity DataEC50:  23nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207950(US9266832, Cpd107)
Affinity DataEC50:  26nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207891(US9266832, Cpd048 | US9266832, Cpd084)
Affinity DataEC50:  26nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207942(US9266832, Cpd099)
Affinity DataEC50:  27nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207919(US9266832, Cpd076)
Affinity DataEC50:  29nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207918(US9266832, Cpd075)
Affinity DataEC50:  30nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207881(US9266832, Cpd038)
Affinity DataEC50:  31nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207885(US9266832, Cpd042)
Affinity DataEC50:  31nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207892(US9266832, Cpd049)
Affinity DataEC50:  31nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207876(US9266832, Cpd033)
Affinity DataEC50:  31nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207880(US9266832, Cpd037)
Affinity DataEC50:  32nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207898(US9266832, Cpd055)
Affinity DataEC50:  36nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207879(US9266832, Cpd036)
Affinity DataEC50:  40nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207897(US9266832, Cpd054)
Affinity DataEC50:  42nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207943(US9266832, Cpd100)
Affinity DataEC50:  44nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207945(US9266832, Cpd102)
Affinity DataEC50:  49nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207893(US9266832, Cpd050)
Affinity DataEC50:  50nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207887(US9266832, Cpd044)
Affinity DataEC50:  55nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207926(US9266832, Cpd083)
Affinity DataEC50:  56nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207878(US9266832, Cpd035)
Affinity DataEC50:  60nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207877(US9266832, Cpd034)
Affinity DataEC50:  62nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207890(US9266832, Cpd047)
Affinity DataEC50:  65nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207902(US9266832, Cpd059)
Affinity DataEC50:  68nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207899(US9266832, Cpd056)
Affinity DataEC50:  70nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207958(US9266832, Cpd115)
Affinity DataEC50:  75nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207935(US9266832, Cpd092)
Affinity DataEC50:  76nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207853(US9266832, Cpd010)
Affinity DataEC50:  78nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207884(US9266832, Cpd041)
Affinity DataEC50:  80nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207922(US9266832, Cpd079)
Affinity DataEC50:  81nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207949(US9266832, Cpd106)
Affinity DataEC50:  82nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207869(US9266832, Cpd026)
Affinity DataEC50:  83nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207872(US9266832, Cpd029)
Affinity DataEC50:  84nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207904(US9266832, Cpd061)
Affinity DataEC50:  86nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207912(US9266832, Cpd069)
Affinity DataEC50:  90nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207933(US9266832, Cpd090)
Affinity DataEC50:  91nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207866(US9266832, Cpd023)
Affinity DataEC50:  94nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207873(US9266832, Cpd030)
Affinity DataEC50:  96nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207932(US9266832, Cpd089)
Affinity DataEC50:  98nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207883(US9266832, Cpd040)
Affinity DataEC50:  103nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAlpha-synuclein(Homo sapiens (Human))
Katholieke Universiteit Levun

US Patent
LigandPNGBDBM207862(US9266832, Cpd019)
Affinity DataEC50:  103nMAssay Description:α-Synucleinopathies are characterised by aggregation of α-synuclein in neurons. Aggregation of purified α-synuclein is performed essen...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 90 total ) | Next | Last >>
Jump to: